Piotr Cywoniuk

Piotr Cywoniuk

Auto-generated profile, based on publicly available information

Piotr Cywoniuk

NanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, Poznań 61-614, Poland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ŁSŁukasz Jakub Sznajder
Łukasz Jakub Sznajder
MMMichał Michalak
Michał Michalak
KTKatarzyna Taylor
Katarzyna Taylor
PCPiotr Cywoniuk
Piotr Cywoniuk
MKMichał Kabza
Michał Kabza
KSKrzysztof Sobczak
Krzysztof Sobczak
Muscleblind-like (MBNL) proteins are critical RNA processing factors in development. MBNL activity is disrupted in the neuromuscular disease myotonic dystrophy type 1 (DM1), due to the instability of a non-coding microsatellite in the DMPK gene and the expression of CUG expansion (CUGexp) RNAs. Pathogenic interactions between MBNL and CUGexp RNA lead to the formation of nuclear complexes termed foci and prevent MBNL function in pre-mRNA processing. The existence of multiple MBNL genes, as well as multiple protein isoforms, raises the question of whether different MBNL proteins possess unique or redundant functions. To address this question, we coexpressed three MBNL paralogs in cells at equivalent levels and characterized both specific and redundant roles of these proteins in alternative splicing and RNA foci dynamics. When coexpressed in the same cells, MBNL1, MBNL2 and MBNL3 bind the same RNA motifs with different affinities. While MBNL1 demonstrated the highest splicing activity, MBNL3 showed the lowest. When forming RNA foci, MBNL1 is the most mobile paralog, while MBNL3 is rather static and the most densely packed on CUGexp RNA. Therefore, our results demonstrate that MBNL paralogs and gene-specific isoforms possess inherent functional differences, an outcome that could be enlisted to improve therapeutic strategies for DM1.

14 October 2022 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
JSJulia Anna Semba
Julia Anna Semba
AMAdam Mieloch
Adam Mieloch
ETEwa Tomaszewska
Ewa Tomaszewska
PCPiotr Cywoniuk
Piotr Cywoniuk
Jakub Dalibor RybkaJakub Dalibor Rybka
Jakub Dalibor Rybka
The necessity to preserve meniscal function prompts the research and develop¬ment of novel treatment options, like three-dimensional (3D) bioprinting. However, bioinks for meniscal 3D bioprinting have not been extensively explored. Therefore, in this study, a bioink composed of alginate, gelatin, and carboxymethylated cellu¬lose nanocrystal (CCNC) was formulated and evaluated. Firstly, bioinks with varying concentrations of the aforementioned components were subjected to rheological analysis (amplitude sweep test, temperature sweep test, and rotation). The optimal bioink formulation of 4.0% gelatin, 0.75% alginate, and 1.4% CCNC dissolved in 4.6% D-mannitol was further used for printing accuracy analysis, followed by 3D bioprint¬ing with normal human knee articular chondrocytes (NHAC-kn). The encapsulated cells’ viability was > 98%, and collagen II expression was stimulated by the bioink. The formulated bioink is printable, stable under cell culture conditions, biocompatible, and able to maintain the native phenotype of chondrocytes. Aside from meniscal tissue bioprinting, it is believed that this bioink could serve as a basis for the devel¬opment of bioinks for various tissues.

14 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PCPiotr Cywoniuk
Piotr Cywoniuk
KTKatarzyna Taylor
Katarzyna Taylor
ŁSŁukasz Jakub Sznajder
Łukasz Jakub Sznajder
KSKrzysztof Sobczak
Krzysztof Sobczak
Alternative splicing is a complex process that provides a high diversity of proteins from a limited number of protein-coding genes. It is governed by multiple regulatory factors, including RNA-binding proteins (RBPs), that bind to specific RNA sequences embedded in a specific structure. The ability to predict RNA-binding regions recognized by RBPs using whole-transcriptome approaches can deliver a multitude of data, including false-positive hits. Therefore, validation of the global results is indispensable. Here, we report the development of an efficient and rapid approach based on a modular hybrid minigene combined with antisense oligonucleotides to enable verification of functional RBP-binding sites within intronic and exonic sequences of regulated pre-mRNA. This approach also provides valuable information regarding the regulatory properties of pre-mRNA, including the RNA secondary structure context. We also show that the developed approach can be used to effectively identify or better characterize the inhibitory properties of potential therapeutic agents for myotonic dystrophy, which is caused by sequestration of specific RBPs, known as muscleblind-like proteins, by mutated RNA with expanded CUG repeats.

4 June 2026 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
AMAdam Mieloch
Adam Mieloch
PCPiotr Cywoniuk
Piotr Cywoniuk
MTMarta Tuszynska
Marta Tuszynska
FPFilip Porzucek
Filip Porzucek
Jakub Dalibor RybkaJakub Dalibor Rybka
Jakub Dalibor Rybka
MWMarta Woźniak-Budych
Marta Woźniak-Budych

11 March 2026 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
YKYasmin Kabalan
Yasmin Kabalan
HBHéloïse Bernarda
Héloïse Bernarda
XMXAVIER MONTANÉ
XAVIER MONTANÉ
TSTomasz Szymański
Tomasz Szymański
PCPiotr Cywoniuk
Piotr Cywoniuk
MWMarta Woźniak-Budych
Marta Woźniak-Budych

14 September 2025 in Food Bioscience
Verified
Journal Article
Open access
MMMagdalena Matwiejczyk
Magdalena Matwiejczyk
PCPiotr Cywoniuk
Piotr Cywoniuk
FPFilip Porzucek
Filip Porzucek
JRJakub Dalibor Rybka
Jakub Dalibor Rybka
MBMonika Besman
Monika Besman
AZAleksandra Zambrowicz
Aleksandra Zambrowicz